ECRP + BCBT for Suicide Risk Reduction
Trial Summary
What is the purpose of this trial?
The suicide rate among active duty service members and Veterans increased substantially following the onset of post-9/11 conflicts in Iraq and Afghanistan. Accordingly, Veteran suicide prevention has been identified as a national healthcare and research priority. The investigators will recruit 136 female and male Veterans who have been hospitalized for suicide risk and randomly assign them to receive one of two psychotherapy treatments for suicide risk after they leave the hospital. The goals of this study are to examine if a) a longer psychotherapy causes greater improvements in coping skills and reductions in negative suicidal thinking, b) a longer psychotherapy is more effective in reducing suicide risk, and c) if Veterans with a history of multiple suicide attempts are more likely to benefit from the longer psychotherapy. Additionally, this study will use magnetic resonance imaging (MRI) neuroimaging scans of Veterans shortly after they leave the hospital and again 4- and 12-months later. This study will explore a) if brain markers can predict suicide attempts, b) if brain markers change over time as suicide risk changes, and c) if brain markers change differently for the two types of psychotherapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment ECRP + BCBT for Suicide Risk Reduction?
Research shows that Brief Cognitive Behavioral Therapy (BCBT) is effective in reducing suicide attempts among military personnel, such as U.S. Army soldiers, and has shown preliminary success in other military groups. Additionally, behavior therapy, which includes components similar to BCBT, has been found to be more effective than other therapies in reducing repeated suicide attempts.12345
Is the ECRP + BCBT treatment generally safe for humans?
How does the ECRP + BCBT treatment for suicide risk reduction differ from other treatments?
The ECRP + BCBT treatment is unique because it combines elements of brief cognitive behavioral therapy (BCBT), which has shown effectiveness in reducing suicide attempts among military personnel, with other components that may enhance its efficacy. This approach is designed to be resource-efficient while specifically targeting suicidal behaviors, unlike more generalized treatments.12348
Research Team
Michael S Esterman, PhD
Principal Investigator
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Eligibility Criteria
This trial is for English-speaking Veterans who've been hospitalized due to recent suicidal thoughts or attempts. They must be able to attend 12 therapy sessions and 3 MRI scans post-discharge. It's not suitable for those with significant cognitive impairments or current psychotic/manic features.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Enhanced Crisis Response Planning (ECRP) or Brief Cognitive Behavioral Therapy (BCBT) for suicide prevention
Neuroimaging
MRI neuroimaging scans are conducted shortly after hospital discharge and again at 4- and 12-months post-discharge
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 2, 4, 8, and 12 months post-discharge
Treatment Details
Interventions
- Brief Cognitive Behavioral Therapy for Suicide Prevention (BCBT)
- Enhanced Crisis Response Planning (ECRP)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor